fda safety concerns bpc-157 immunogenicity Review: Doctor Explains Benefits, & Cancer Risk FDA Scientists Raise Peptide Concerns
Description
European neurology , 23 5, 372-85

Not bactericidal, which kills bacteria

bioinfo.dcc.ufmg.br

The improvements were measurable both biochemically and through micro and macroscopic observation

Doubling your BPC-157 dose from 250 mcg to 500 mcg does not double the healing speed
